LIGAND PHARMACEUTICALS INC Quarterly Common Stock, Shares, Issued from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Ligand Pharmaceuticals Inc quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q3 2024.
  • Ligand Pharmaceuticals Inc Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 18.8M shares, a 7.69% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 18.8M +1.34M +7.69% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 18.1M +751K +4.33% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 17.9M +790K +4.61% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 17.6M +605K +3.57% Dec 31, 2023 10-Q 2024-11-08
Q3 2023 17.4M +527K +3.12% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 17.4M +470K +2.78% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 17.1M +273K +1.62% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 17M +184K +1.1% Dec 31, 2022 10-K 2024-02-29
Q3 2022 16.9M +187K +1.12% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 16.9M +206K +1.24% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 16.9M +209K +1.26% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 16.8M +687K +4.27% Dec 31, 2021 10-K 2023-02-28
Q3 2021 16.7M +616K +3.83% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 16.7M +605K +3.77% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 16.7M +602K +3.75% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 16.1M -743K -4.42% Dec 31, 2020 10-K 2022-02-28
Q3 2020 16.1M -1.47M -8.38% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 16.1M -3.32M -17.1% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 16.1M -3.61M -18.4% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 16.8M -3.94M -19% Dec 31, 2019 10-K 2021-02-24
Q3 2019 17.6M -3.53M -16.7% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 19.4M -1.71M -8.08% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 19.7M -1.64M -7.69% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 20.8M -383K -1.81% Dec 31, 2018 10-K 2020-02-27
Q3 2018 21.1M +338 +0% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 21.1M +45.4K +0.22% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 21.3M +306K +1.46% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 21.1M +239K +1.15% Dec 31, 2017 10-K 2019-02-28
Q3 2017 21.1M +196K +0.94% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 21M +197K +0.94% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 21M +180K +0.87% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 20.9M +960K +4.81% Dec 31, 2016 10-K 2018-03-01
Q3 2016 20.9M +981K +4.92% Sep 30, 2016 10-Q 2016-11-15
Q2 2016 20.9M +1.02M +5.12% Jun 30, 2016 10-Q/A 2016-11-15
Q1 2016 20.8M +1.16M +5.89% Mar 31, 2016 10-Q/A 2016-11-15
Q4 2015 19.9M +374K +1.91% Dec 31, 2015 10-K 2017-02-28
Q3 2015 19.9M -199K -0.99% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 19.8M -941K -4.53% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 19.7M -1.06M -5.11% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 19.6M -893K -4.37% Dec 31, 2014 10-K/A 2016-11-15
Q3 2014 20.1M -1.41M -6.56% Sep 30, 2014 10-Q 2014-10-31
Q2 2014 20.8M -657K -3.07% Jun 30, 2014 10-Q 2014-08-05
Q1 2014 20.7M -626K -2.93% Mar 31, 2014 10-Q 2014-05-07
Q4 2013 20.5M -810K -3.81% Dec 31, 2013 10-K 2015-02-23
Q3 2013 21.5M +446K +2.11% Sep 30, 2013 10-Q 2013-11-08
Q2 2013 21.4M +531K +2.54% Jun 30, 2013 10-Q 2013-08-01
Q1 2013 21.3M +490K +2.35% Mar 31, 2013 10-Q 2013-05-08
Q4 2012 21.3M +596K +2.88% Dec 31, 2012 10-K/A 2014-12-12
Q3 2012 21.1M +403K +1.95% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 20.9M +228K +1.11% Jun 30, 2012 10-Q/A 2012-11-14
Q1 2012 20.9M Mar 31, 2012 10-Q/A 2012-11-14
Q4 2011 20.7M +61.6K +0.3% Dec 31, 2011 10-K 2013-03-14
Q3 2011 20.7M Sep 30, 2011 10-Q/A 2012-02-10
Q2 2011 20.7M Jun 30, 2011 10-Q/A 2012-02-10
Q4 2010 20.6M Dec 31, 2010 10-K/A 2012-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.